Initiation of Antiresorptive Drug Treatment during Endocrine Therapy for Breast Cancer—A Retrospective Cohort Study of 161,492 Patients in Germany

Endocrine therapy (ET), which significantly reduces breast cancer (BC) recurrence and mortality rates, is the primary systemic therapy for hormone receptor positive BC. However, in addition to frequently reported TAM- and AI-related side effects, such as hot flashes, arthralgias, and myalgias, treat...

Descripción completa

Detalles Bibliográficos

Autores principales:	Gremke, Niklas, Griewing, Sebastian, Kadys, Arturas, Kostev, Karel, Wagner, Uwe, Kalder, Matthias
Formato:	Artículo
Lenguaje:	inglés
Publicado:	Philipps-Universität Marburg 2023
Materias:	endocrine therapy denosumab Medizin bisphosphonates Germany breast cancer tamoxifen antiresorptive therapy aromatase inhibitors Medical sciences Medicine
Acceso en línea:	Texto Completo PDF
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!